School of Medicine
Showing 471-480 of 557 Results
-
Steven Asch
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsDescribe your current research interest and activities
-
Ryan T. Ash MD, PhD
Instructor, Psychiatry and Behavioral Sciences
BioMy lab is interested in developing novel neuromodulation technologies to augment neuroplasticity and enhance the "unlearning" of maladaptive habitual ways of relating to the to the world. I have a K08 Career Development Award to measure how attention modulates neuroplasticity induced by repetitive transcranial magnetic stimulation, using EEG steady-state visual evoked potentials and visual attention psychophysics. I have a Brain Behavior Research Foundation Young Investigator Award to develop in-human applications of transcranial ultrasound stimulation in the subcortical visual system and fear regulation circuit. I have a Simons Foundation Bridge to independence Award to develop closed-loop ultrasound neuromodulation technologies to enhance behavioral flexibility in autism spectrum disorders. I work closely with mentors Anthony Norcia, Kim Butts Pauly, and Nolan Williams on these projects. I am interested in the neural basis of mindfulness, concentration, and compassion practices from Buddhist meditation, and I have more than a year of silent retreat experience in the Theravada Buddhist meditation tradition. I see patients in the Stanford Neuropsychiatry clinic with a specialization in Functional Neurological disorders and related psychosomatic and dissociative conditions. My therapeutic orientations include integrated psychodynamic- and mindfulness-based approaches and neuromodulation-assisted psychotherapy.
-
Euan A. Ashley
Roger and Joelle Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
